Cymbalta and HYPERHIDROSIS

6,883 reports of this reaction

1.6% of all Cymbalta reports

#17 most reported adverse reaction

Overview

HYPERHIDROSIS is the #17 most commonly reported adverse reaction for Cymbalta, manufactured by Eli Lilly and Company. There are 6,883 FDA adverse event reports linking Cymbalta to HYPERHIDROSIS. This represents approximately 1.6% of all 439,614 adverse event reports for this drug.

Patients taking Cymbalta who experience hyperhidrosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HYPERHIDROSIS6,883 of 439,614 reports

HYPERHIDROSIS is a less commonly reported adverse event for Cymbalta, but still significant enough to appear in the safety profile.

Other Side Effects of Cymbalta

In addition to hyperhidrosis, the following adverse reactions have been reported for Cymbalta:

NAUSEA — 17,699 reports
FATIGUE — 15,796 reports
DRUG INEFFECTIVE — 13,910 reports
HEADACHE — 13,507 reports
DIZZINESS — 13,252 reports
PAIN — 12,206 reports
DIARRHOEA — 9,854 reports
INSOMNIA — 9,750 reports
OFF LABEL USE — 9,736 reports
ANXIETY — 9,598 reports

Other Drugs Associated with HYPERHIDROSIS

The following drugs have also been linked to hyperhidrosis in FDA adverse event reports:

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE ALUMINUM CHLORIDE APIS MELLIFERA BRYONIA ALBA ROOT BUPRENORPHINE AND NALOXONE BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE CARBOPROST TROMETHAMINE CYCLOBENZAPRINE HYDROCHLORIDE DESVENLAFAXINE SUCCINATE DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE DIHYDROERGOTAMINE MESYLATE DULOXETINE HYDROCHLORIDE FLUDEOXYGLUCOSE F 18 KETAMINE HYDROCHLORIDE KETOPROFEN MEPERIDINE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE MILNACIPRAN HYDROCHLORIDE NORTRIPTYLINE HYDROCHLORIDE RIZATRIPTAN BENZOATE

Frequently Asked Questions

Does Cymbalta cause HYPERHIDROSIS?

HYPERHIDROSIS has been reported as an adverse event in 6,883 FDA reports for Cymbalta. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HYPERHIDROSIS with Cymbalta?

HYPERHIDROSIS accounts for approximately 1.6% of all adverse event reports for Cymbalta, making it a notable side effect.

What should I do if I experience HYPERHIDROSIS while taking Cymbalta?

If you experience hyperhidrosis while taking Cymbalta, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Cymbalta Full Profile All Drugs Causing HYPERHIDROSIS Eli Lilly and Company Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.